Legal Status Overview
Gray AreaMaryland has no statute, regulation, or Board of Pharmacy rule that names "peptides" or "research chemicals" as their own legal category; the state instead relies entirely on the federal Food, Drug & Cosmetic Act (FDCA) and the Maryland Board of Pharmacy's general compounding regulations (COMAR 10.34.19, mirroring federal 503A/503B rules) to govern which peptides pharmacies may prepare and dispense. Research-use peptides like BPC-157 and TB-500 remain unapproved drugs under FDA rules and have already been the subject of a federal criminal prosecution in the District of Maryland for being sold to consumers as misbranded/unapproved drugs behind a "research chemical" label. GLP-1 peptides (semaglutide, tirzepatide) and some other compounded peptides can be legally dispensed in Maryland when prepared by a licensed compounding pharmacy against a valid, patient-specific prescription, subject to whatever is currently on the FDA's 503A Bulk Drug Substances list.
Key Points
- Maryland has no statute or Board of Pharmacy regulation that specifically names "peptides" or "research chemicals" as a distinct legal category; Maryland's compounding law defines compounding generally as preparation done under a valid prescription or for research/teaching purposes not intended for sale. [5]
- The Maryland Board of Pharmacy regulates sterile and nonsterile compounding under COMAR 10.34.19, which requires pharmacies to meet USP 795/797 standards and undergo Board inspection, incorporating the federal 503A/503B framework rather than creating a separate peptide category. [6]
- A federal prosecution in the District of Maryland resulted in a defendant being sentenced to home confinement and ordered to forfeit over $2 million after selling FDA-unapproved peptides to bodybuilders under misbranded-drug labeling, showing that Maryland-based sale of research peptides for human use has already been treated as a federal crime. [4]
- An earlier Maryland-based federal indictment specifically targeted a seller who obtained growth-hormone-related peptides (including CJC-1295 and GHRP-6) from research-chemical suppliers under false research pretenses and resold them to consumers, illustrating enforcement of federal unapproved-drug law against HGH-related peptides in Maryland. [9]
- Compounded semaglutide and tirzepatide are described as permitted in Maryland when prepared by a licensed 503A/503B pharmacy under a valid patient-specific prescription, and Maryland allows full telehealth prescribing for this workflow with no in-person visit required before the first prescription. [7]
- Whether a compounding pharmacy in Maryland may legally prepare a given peptide (such as BPC-157, TB-500, or sermorelin) depends on whether that peptide is FDA-approved, appears on a USP monograph, or is listed on the FDA's Section 503A Bulk Drug Substances List, since peptides over roughly 40 amino acids are treated as biologics that 503A pharmacies cannot legally compound at all. [8]
- A person cannot lawfully bring in, buy, or personally import unapproved research peptides like BPC-157 or TB-500 for use in Maryland outside a valid prescription, because the FDA classifies them as unapproved drugs regardless of "research use only" or "not for human consumption" labeling. [1]
- As of mid-2026 the FDA's Pharmacy Compounding Advisory Committee was still reviewing whether BPC-157, TB-500, and related peptides should be added to the federal 503A Bulk Drug Substances List, meaning their compounding status even under Maryland-licensed pharmacies remained federally unresolved and subject to change. [2]
Peptide-by-peptide status in Maryland
| BPC-157 | BPC-157 is not legal for human sale or administration in Maryland because the FDA classifies it as an unapproved drug that cannot be legally prescribed or sold over the counter, and its compounding status remained under federal review (not yet on the 503A Bulks List) as of mid-2026. [1] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | Semaglutide and tirzepatide can be legally obtained in Maryland as compounded medications when a licensed provider writes a valid patient-specific prescription filled by a Maryland 503A pharmacy or supplied by a 503B outsourcing facility, including via telehealth. [7] |
| TB-500 | TB-500 is treated the same as BPC-157 in Maryland: it is an unapproved research peptide whose compounding for human use has not been approved and was still pending FDA Pharmacy Compounding Advisory Committee review for the 503A Bulks List as of July 2026. [2] |
| Human Growth Hormone (HGH) / GH-releasing peptides (e.g., CJC-1295, GHRP-6) | HGH-related peptides sold outside a legitimate FDA-approved prescription pathway have already been federally prosecuted as unapproved/misbranded drugs when distributed to Maryland consumers under a "research chemical" cover story, so recreational or bodybuilding use of these peptides in Maryland carries real federal criminal exposure. [9] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides like BPC-157 in Maryland without a prescription?
No -- in Maryland, buying BPC-157 or similar research peptides without a prescription for human use is not legal, because the FDA treats them as unapproved drugs and "research use only" or "not for human consumption" labels do not change that status. [1]
Is it legal to bring peptides into Maryland from another state or country for personal use?
Personally importing or transporting unapproved research peptides such as BPC-157 or TB-500 into Maryland for human use is not a lawful workaround, since federal law governs the products regardless of state lines and prior Maryland federal prosecutions have targeted exactly this kind of unauthorized distribution. [4]
Can a Maryland telehealth doctor legally prescribe compounded semaglutide or tirzepatide?
Yes -- Maryland allows full telehealth prescribing of compounded GLP-1 medications like semaglutide and tirzepatide, and a patient can consult a licensed provider remotely with no in-person visit required before the first prescription, as long as a Maryland-licensed compounding pharmacy fills it. [7]
What happens if someone is caught selling research peptides in Maryland?
Selling unapproved peptides for human use in Maryland can result in federal criminal prosecution, as shown by a District of Maryland case where a seller was sentenced to home confinement, probation, and forfeiture of over $2 million for distributing misbranded peptide products to bodybuilders. [4]
Does Maryland have its own peptide law separate from federal FDA rules?
No -- Maryland has no peptide-specific statute or Board of Pharmacy rule; it regulates peptides only through its general compounding regulations (COMAR 10.34.19), which incorporate the same federal 503A/503B compounding framework used nationwide. [6]